Fucoxanthin: a Marine Carotenoid Exerting Anti-cancer Effects by Affecting Multiple Mechanisms

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2013 Dec 20

PMID 24351910

Citations 70

Authors

Sangeetha Ravi Kumar

Masashi Hosokawa

Kazuo Miyashita

Affiliations

Soon will be listed here.

Abstract

Fucoxanthin is a marine carotenoid exhibiting several health benefits. The anti-cancer effect of fucoxanthin and its deacetylated metabolite, fucoxanthinol, is well documented. In view of its potent anti-carcinogenic activity, the need to understand the underlying mechanisms has gained prominence. Towards achieving this goal, several researchers have carried out studies in various cell lines and in vivo and have deciphered that fucoxanthin exerts its anti-proliferative and cancer preventing influence via different molecules and pathways including the Bcl-2 proteins, MAPK, NFκB, Caspases, GADD45, and several other molecules that are involved in either cell cycle arrest, apoptosis, or metastasis. Thus, in addition to decreasing the frequency of occurrence and growth of tumours, fucoxanthin has a cytotoxic effect on cancer cells. Some studies show that this effect is selective, i.e., fucoxanthin has the capability to target cancer cells only, leaving normal physiological cells unaffected/less affected. Hence, fucoxanthin and its metabolites show great promise as chemotherapeutic agents in cancer.

Citing Articles

RNA Editing Analysis Reveals Methyl Jasmonic Acid Regulation of Fucoxanthin and Fatty Acid Metabolism in .

Huang S, Liu H, Xu R, Li W, Yang H, Bao X Mar Drugs. 2025; 23(2).

PMID: 39997190 PMC: 11857586. DOI: 10.3390/md23020066.

Characterization of microalgal β-carotene and astaxanthin: exploring their health-promoting properties under the effect of salinity and light intensity.

Aditi , Bhardwaj R, Yadav A, Swapnil P, Meena M Biotechnol Biofuels Bioprod. 2025; 18(1):18.

PMID: 39953577 PMC: 11829443. DOI: 10.1186/s13068-025-02612-x.

Anticancer Activity of Plant Tocotrienols, Fucoxanthin, Fucoidan, and Polyphenols in Dietary Supplements.

Lara-Hernandez G, Ramos-Silva J, Perez-Soto E, Figueroa M, Flores-Berrios E, Sanchez-Chapul L Nutrients. 2025; 16(24.

PMID: 39770896 PMC: 11678266. DOI: 10.3390/nu16244274.

Citrus Carotenoid Extracts Promote ROS Accumulation and Induce Oxidative Stress to Exert Anti-Proliferative and Pro-Apoptotic Effects in MDA-MB-231 Cells.

Wei J, Ye Z, Li Y, Li Y, Zhou Z Antioxidants (Basel). 2024; 13(3).

PMID: 38539798 PMC: 10967589. DOI: 10.3390/antiox13030264.

Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies.

Dalisay D, Tenebro C, Sabido E, Suarez A, Paderog M, Reyes-Salarda R Mar Drugs. 2024; 22(3).

PMID: 38535455 PMC: 10972102. DOI: 10.3390/md22030114.

References

Nomura T, Kikuchi M, Kubodera A, Kawakami Y . Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem Mol Biol Int. 1997; 42(2):361-70. DOI: 10.1080/15216549700202761. View

Okai Y, Nakamura S . Identification of heterogenous antimutagenic activities in the extract of edible brown seaweeds, Laminaria japonica (Makonbu) and Undaria pinnatifida (Wakame) by the umu gene expression system in Salmonella typhimurium (TA1535/pSK1002). Mutat Res. 1993; 303(2):63-70. DOI: 10.1016/0165-7992(93)90096-e. View

Ravi Kumar S, Narayan B, Vallikannan B . Fucoxanthin restrains oxidative stress induced by retinol deficiency through modulation of Na(+)K(+)-ATPase [corrected] and antioxidant enzyme activities in rats. Eur J Nutr. 2008; 47(8):432-41. DOI: 10.1007/s00394-008-0745-4. View

Teas J, Vena S, Cone D, Irhimeh M . The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle. J Appl Phycol. 2013; 25(3):771-779. PMC: 3651528. DOI: 10.1007/s10811-012-9931-0. View

Konishi I, Hosokawa M, Sashima T, Kobayashi H, Miyashita K . Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp Biochem Physiol C Toxicol Pharmacol. 2005; 142(1-2):53-9. DOI: 10.1016/j.cbpc.2005.10.005. View

Kim K, Heo S, Kang S, Ahn G, Jeon Y . Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol In Vitro. 2010; 24(6):1648-54. DOI: 10.1016/j.tiv.2010.05.023. View

Cepeda V, Fuertes M, Castilla J, Alonso C, Quevedo C, Perez J . Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007; 7(1):3-18. DOI: 10.2174/187152007779314044. View

Zorbas H, Keppler B . Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?. Chembiochem. 2005; 6(7):1157-66. DOI: 10.1002/cbic.200400427. View

Das S, Hashimoto T, Kanazawa K . Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim Biophys Acta. 2008; 1780(4):743-9. DOI: 10.1016/j.bbagen.2008.01.003. View

10.

Hashimoto T, Ozaki Y, Mizuno M, Yoshida M, Nishitani Y, Azuma T . Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract. Br J Nutr. 2011; 107(11):1566-9. DOI: 10.1017/S0007114511004879. View

11.

Aust O, Ale-Agha N, Zhang L, Wollersen H, Sies H, Stahl W . Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol. 2003; 41(10):1399-407. DOI: 10.1016/s0278-6915(03)00148-0. View

12.

Matsumoto M, Hosokawa M, Matsukawa N, Hagio M, Shinoki A, Nishimukai M . Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur J Nutr. 2009; 49(4):243-9. DOI: 10.1007/s00394-009-0078-y. View

13.

Asai A, Sugawara T, Ono H, Nagao A . Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Drug Metab Dispos. 2004; 32(2):205-11. DOI: 10.1124/dmd.32.2.205. View

14.

Deryugina E, Quigley J . Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006; 25(1):9-34. DOI: 10.1007/s10555-006-7886-9. View

15.

Okuzumi J, Nishino H, Murakoshi M, Iwashima A, Tanaka Y, Yamane T . Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett. 1990; 55(1):75-81. DOI: 10.1016/0304-3835(90)90068-9. View

16.

Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A . Carotenoids affect proliferation of human prostate cancer cells. J Nutr. 2001; 131(12):3303-6. DOI: 10.1093/jn/131.12.3303. View

17.

Adams J, Cory S . Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol. 2007; 19(5):488-96. PMC: 2754308. DOI: 10.1016/j.coi.2007.05.004. View

18.

Shimoda H, Tanaka J, Shan S, Maoka T . Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. J Pharm Pharmacol. 2010; 62(9):1137-45. DOI: 10.1111/j.2042-7158.2010.01139.x. View

19.

Satomi Y, Nishino H . Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim Biophys Acta. 2009; 1790(4):260-6. DOI: 10.1016/j.bbagen.2009.01.003. View

20.

Liebermann D, Tront J, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B . Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog. 2011; 16(1-2):129-40. PMC: 3268054. DOI: 10.1615/critrevoncog.v16.i1-2.120. View